-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/telehealth-acute-chronic_research-protocol.pdf
February 15, 2017 - diagnosis and treatment of infectious disease or specific conditions (e.g., upper
respiratory infection, hepatitis … C, skin infections) or decisions (e.g., stewardship
of antibiotics or antimicrobials, selection of … Characteristics of the providers and patients involved
c.
-
hcup-us.ahrq.gov/db/nation/nrd/Introduction_NRD_2010-2017.jsp
January 01, 2017 - STATE-SPECIFIC RESTRICTIONS
Table C.1. … Table C.1. … Mycoses
10,755
27.56
28.10
2.0
5: HIV infection
7,495
26.99
27.66
2.5
6: Hepatitis … including parasitic
4,117
13.46
14.09
4.7
9: Sexually transmitted infections (not HIV or hepatitis … Andrews R, Kassed C, Nagamine M.
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2011_MaskedStats_Severity.PDF
January 01, 2011 - disorders 7,450 0.09%
540: Cesarean delivery 264,965 3.30%
541: Vaginal delivery w sterilization &/or D&C … 17,490 0.22%
542: Vaginal delivery w complicating procedures exc sterilization &/or D&C 1,699 0.02% … 544: D&C, aspiration curettage or hysterotomy for obstetric diagnoses 4,462 0.06%
545: Ectopic pregnancy … abortion diagnoses w/o procedure 11,651 0.15%
563: Threatened abortion 12,713 0.16%
564: Abortion w/o D&C,
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/psoriasis-chronic_executive.pdf
November 01, 2012 - Citations excluded at the full-text level are listed in
Appendix C in the full report, along with the … Gisondi P, Del Giglio M, Cotena C, et al. … Gisondi P, Cotena C, Tessari G, et al. … Magliocco MA, Lozano AM, Van Saders C, et al.
-
hcup-us.ahrq.gov/db/nation/nrd/stats/NRD_2012_MaskedStats_Severity_V2.PDF
January 01, 2012 - Percent
of Total
540: Cesarean delivery 521,823 3.88%
541: Vaginal delivery w sterilization &/or D&C … 26,033 0.19%
542: Vaginal delivery w complicating procedures exc sterilization &/or D&C 3,015 0.02% … 544: D&C, aspiration curettage or hysterotomy for obstetric diagnoses 7,331 0.05%
545: Ectopic pregnancy … abortion diagnoses w/o procedure 22,592 0.17%
563: Preterm labor 23,187 0.17%
564: Abortion w/o D&C,
-
hcup-us.ahrq.gov/db/nation/nrd/stats/NRD_2011_MaskedStats_V2_Severity.PDF
January 01, 2011 - Percent
of Total
540: Cesarean delivery 534,930 3.84%
541: Vaginal delivery w sterilization &/or D&C … 28,625 0.21%
542: Vaginal delivery w complicating procedures exc sterilization &/or D&C 3,223 0.02% … 544: D&C, aspiration curettage or hysterotomy for obstetric diagnoses 9,667 0.07%
545: Ectopic pregnancy … abortion diagnoses w/o procedure 22,748 0.16%
563: Threatened abortion 25,561 0.18%
564: Abortion w/o D&C,
-
hcup-us.ahrq.gov/db/nation/nrd/stats/NRD_2010_MaskedStats_Severity_V2.PDF
January 01, 2010 - Percent
of Total
540: Cesarean delivery 539,914 3.88%
541: Vaginal delivery w sterilization &/or D&C … 29,710 0.21%
542: Vaginal delivery w complicating procedures exc sterilization &/or D&C 3,468 0.02% … 544: D&C, aspiration curettage or hysterotomy for obstetric diagnoses 8,021 0.06%
545: Ectopic pregnancy … abortion diagnoses w/o procedure 23,183 0.17%
563: Threatened abortion 26,513 0.19%
564: Abortion w/o D&C,
-
hcup-us.ahrq.gov/db/nation/nrd/stats/NRD_2013_MaskedStats_Severity.PDF
January 01, 2013 - disorders 12,625 0.09%
540: Cesarean delivery 553,991 3.87%
541: Vaginal delivery w sterilization &/or D&C … 27,470 0.19%
542: Vaginal delivery w complicating procedures exc sterilization &/or D&C 3,091 0.02% … 544: D&C, aspiration curettage or hysterotomy for obstetric diagnoses 7,164 0.05%
545: Ectopic pregnancy … abortion diagnoses w/o procedure 23,907 0.17%
563: Preterm labor 22,029 0.15%
564: Abortion w/o D&C,
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/kidney-disease-medicine_surveillance.pdf
October 01, 2012 - ...................................................................................... 26
Appendix C. … Appendix C shows the questionnaire matrix that was sent to
the experts.
2.4 Check for qualitative … Comparison of measured GFR, serum
creatinine, cystatin C, and beta-trace protein
to predict ESRD in … Goraya N, Simoni J, Jo C, et al. … Evidence Table
Appendix C. Questionnaire Matrix
-
psnet.ahrq.gov/sites/default/files/2023-11/spotlight_case_the_risk_of_malpositioned.pdf
January 01, 2023 - on the patient’s body habitus,
making sure that the bolster is neither too tight
nor too loose; (C) … Gawande RS, Bailey CR, Jones C, et al. … Patel BB, Andrade C, Doraiswamy V, et al. … Gubler C, Wildi SM, Bauerfeind P. Liver injury during PEG tube placement: report of two cases. … Korula J, Harma C. A simple and inexpensive method of removal or replacement of gastrostomy tubes.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/grades-predictive-values_white-paper-2015.pdf
January 01, 2015 - c. … Charoenkwan K, Kietpeerakool C. … Hepatitis A immunisation in persons not
previously exposed to hepatitis A. … Interferon for interferon
nonresponding and relapsing patients with
chronic hepatitis C. … Main C, Knight B, Moxham T, et al.
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/syphilis-infection-in-pregnancy-screening-2009
May 15, 2009 - screening for other sexually transmitted diseases in pregnancy, including gonorrhea, chlamydial infection, hepatitis … [PMID: 15306757]
Wolff T, Shelton E, Sessions C, Miller T.
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/unhealthy-alcohol-use-in-adolescents-and-adults-screening-and-behavioral-counseling-interventions
October 20, 2016 - for adolescents)
Alcohol Use Disorders Identification Test (AUDIT), its abbreviated version (AUDIT-C) … health symptoms/disorders; alcohol-related liver problems, including fatty liver disease, alcoholic hepatitis
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan18/drug-use-illicit-primary-care-interventions-for-children-and-adolescents-march-2014
May 15, 2013 - including, but not limited to: mental health disorders, sexually transmitted infection/HIV transmission, hepatitis … B or C transmission, unintended pregnancies/pregnancy complications, respiratory infections, cardiovascular
-
integrationacademy.ahrq.gov/products/playbooks/opioid-use-disorder/implement-mat-for-oud/screening-and-diagnosis
January 01, 2018 - of opioid use disorder; Other relevant medical conditions (i.e., pregnancy testing, liver function, hepatitis … B and C testing, HIV testing); and Other relevant psychiatric disorders, including depression and specifically
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/juvenile-arthritis-dmards_surveillance.pdf
March 14, 2013 - ...................................................................................... 19
Appendix C. … Gaujoux-Viala C, Giampietro C, Gaujoux
T, et al. Scleritis: a paradoxical effect of
etanercept? … Sandborg C, Mellins ED. A new era in
the treatment of systemic juvenile idiopathic
arthritis. … C-reactive
protein and ferritin normalized
within this interval in >80%. … AE’s included
bacterial infection in 2 patients
and hepatitis in 1
Key Question 2: In children with
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/juvenile-arthritis-dmards_surveillance.pdf
March 14, 2013 - ...................................................................................... 19
Appendix C. … Gaujoux-Viala C, Giampietro C, Gaujoux
T, et al. Scleritis: a paradoxical effect of
etanercept? … Sandborg C, Mellins ED. A new era in
the treatment of systemic juvenile idiopathic
arthritis. … C-reactive
protein and ferritin normalized
within this interval in >80%. … AE’s included
bacterial infection in 2 patients
and hepatitis in 1
Key Question 2: In children with
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/drug-abuse-screening-1996
January 01, 1996 - complications from injecting contaminated materials (e.g., human immunodeficiency virus [HIV] infection, hepatitis … Colmorgen GHC, Johnson C, Zazzarino MA, et al. … Chasnoff IJ, Griffith DR, Freier C, Murray J. … Wickizer T, Maynard C, Atherly A, et al. … Power R, Hartnoll R, Chalmers C.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/infantile-hemangioma_disposition-comments.pdf
January 15, 2016 - Research Review Citation: Chinnadurai S, Snyder K, Sathe N, Fonnesbeck C, Morad A,
Likis FE, Surawicz … T, Ness G, Ficzere C, McPheeters ML. … Peer reviewer #1 Methods Fig C- Final Health Outcomes: is there a causation for
problems with thyroid … Timolol – 64% clearance
c. intralesionalTriamcinolone – 54%
d.
-
cds.ahrq.gov/sites/default/files/cds/artifact/18/Implementation%20Guide_USPSTF%20Statin%20Use%20for%20the%20Primary%20Prevention%20of%20CVD%20in%20Adults_Final.docx
October 01, 2017 - Patient is likely to have adverse reactions to statins.
c. … abnormal blood cholesterol, represented HDL-C < 40 mg/dL or LDL-C > 130 mg/dL
Grade B and C
"Diabetes … "
Type 1 and Type 2 Diabetes
Grade B and C
"Hypertension"
high blood pressure
Grade B and C
" … the work group, not all liver conditions clearly exclude a recommendation for statin therapy (e.g., Hepatitis … B and C).